查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1515444

基因组生物标记市场，按类型、疾病适应症、验证、最终用户和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Genomic Biomarker Market, By Type, By Disease Indication, By Validation, By End User, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023 年，基因组生物标记市场规模为 76.842 亿美元，2024 年至 2032 年复合年增长率为 18.20%。

基因组生物标记市场-市场动态

癌症盛行率不断上升推动市场成长

由于肺癌、前列腺癌、卵巢癌和乳腺癌等各种癌症的盛行率不断上升，预计对基因组生物标记的市场需求将会增加。针对器官系统和疾病是人类健康生物标记的目标。特别是，生物标记在治疗、重症监护和基于疾病的诊断的医疗程序中变得越来越常见。为了改善包括癌症和心血管疾病在内的慢性疾病的检测和管理，全世界对遗传生物标记的需求日益增长。这导致预计期内市场对基因组生物标记的需求增加。

基因组生物标记市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 18.20% 左右的复合年增长率成长

根据类型细分，预测生物标记类别预计将在 2023 年显示最大的市场份额

依疾病适应症细分，2023年肿瘤类别为主导类型

基于终端用户细分，诊断品类为2023年主导类型

按地区划分，北美是 2023 年的主要收入来源

基因组生物标记市场-細項分析：

全球基因组生物标记市场根据类型、疾病适应症、验证、最终用户和地区进行细分。

市场根据类型分为两类：预测生物标记和预后生物标记。预测生物标誌类别主导市场。此细分市场受益的原因是预测生物标记是治疗前或基线资料，表明患者从特定治疗中受益或不受益的可能性。当创建特定的治疗药物时，通常选择预测生物标记作为伴随生物标记。肿瘤学中的一个常见例子是一种生物标记物，如果它能够识别生长因子蛋白Her-2 的过度表现（这种蛋白会导致乳癌细胞增殖），那么该生物标记就可以用来预测何时施用曲妥珠单抗（赫赛汀）。对于乳癌患者，这种药物可以阻断 Her-2 的作用。因此，对预测性生物标记的需求随之增长。鑑于上述说法，可以推断，在预测期内，该细分市场将拥有最大的市场份额。

根据疾病适应症，市场分为以下几类：肿瘤、心血管疾病、神经系统疾病、肾臟疾病等。肿瘤学类别在市场中占据主导地位，并可能在预测期内保持其主导地位。全球癌症患者数量的不断增加以及生物标记方法不断取得的技术突破是造成这一重大利害关係的原因。近年来，基因组生物标记在肿瘤学中有许多可能的用途，包括风险评估、预测确定、鑑别诊断筛检、追踪癌症病程和治疗反应预测。根据世界卫生组织 (WHO) 的数据，癌症是全球第二大常见死因，占低收入和中等收入国家死亡人数的 70%。此外，根据世界卫生组织估计，2018 年全球报告的癌症死亡人数为 960 万人，新增癌症病例为 1,810 万例。

基因组生物标记市场-地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太地区、中东和非洲地区。这些区域根据开展业务的国家进一步划分。

在预测期内，北美预计将占据全球基因组生物标记市场的最大份额。该地区饮食和生活方式的转变导致慢性病发病率不断上升，这将确保其主导地位。由于製药业越来越多地使用技术，基因组生物标记市场不断增长。由于美国、加拿大等国家加强研发力度，基因组生物标记市场预计将成长。

此外，预计亚太地区的基因组生物标记市场将以全球最快的速度扩张。预计对该地区市场扩张贡献最大的国家为中国、日本、韩国和印度。公共和私人组织为推动製药业的发展投入了大量资金，支持亚太市场的扩张。预计亚太地区市场的扩张将受到对各种基因检测计划和与医疗保健行业进步相关的研究的日益重视的推动。

基因组生物标记市场-竞争格局：

基因组生物标记市场的主要参与者包括 Thermo Fisher Scientific（美国）、F. Hoffmann-La Roche Ltd（瑞士）、Myriad Genetics, Inc（美国）、Eurofins Scientific（卢森堡）和 QIAGEN（德国）等。强调的一项或多项成长策略是併购；其他策略包括有关合作伙伴之间策略协作、相互协议和伙伴关係的趋势和分析。为了扩大其地理影响力，各大公司正在实施新产品发布的前沿策略。

最近的发展：

2023 年 5 月：英国 MHRA 和 Genomics England 联合表示，他们已成立一家合资企业，开发尖端资源，以了解一个人的基因组成如何影响药物的安全性。

2023 年 5 月：京都大学、富士通和 Chordia Therapeutics 宣布建立策略伙伴关係，开始一项旨在识别新型癌症治疗生物标记的人工智慧试验。这些发现促成了合作的目标，即开发适合每位患者的新型癌症疗法。

2022 年 10 月：北卡罗来纳州的 Biofidelity 推出首款商业产品，表示将资助 2,300 万美元来维持其肺癌的 ASPYRE-Lung 诊断检测。

目录

第 1 章：基因组生物标记市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按类型分類的基因组生物标记市场片段
    • 依疾病指示分類的基因组生物标记市场片段
    • 经验证的基因组生物标记市场片段
    • 最终用户的基因组生物标记市场片段
    • 按国家/地区分類的基因组生物标记市场片段
    • 按地区分類的基因组生物标记市场片段
  • 竞争洞察

第 3 章：基因组生物标记主要市场趋势

  • 基因组生物标记市场驱动因素
    • 市场驱动因素的影响分析
  • 基因组生物标记市场限制
    • 市场限制影响分析
  • 基因组生物标记市场机会
  • 基因组生物标记市场未来趋势

第 4 章：基因组生物标记产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：基因组生物标记市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：基因组生物标记市场格局

  • 2023 年基因组生物标记市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：基因组生物标记市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 预测性生物标记
    • 预后生物标记

第 8 章：基因组生物标记市场 - 依疾病指示

  • 概述
    • 按疾病适应症分類的细分市场份额分析
    • 肿瘤学
    • 心血管疾病
    • 神经系统疾病
    • 肾臟疾病
    • 其他的

第 9 章：基因组生物标记市场 - 透过验证

  • 概述
    • 透过验证进行细分市场占有率分析
    • 分析验证
    • 临床验证
    • 临床实用性

第 10 章：基因组生物标记市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 诊断
    • 研究实验室
    • 医院
    • 其他的

第 11 章：基因组生物标记市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美基因组生物标记主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按类型）
    • 北美市场规模与预测（按疾病适应症）
    • 北美市场规模与预测（经验证）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲基因组生物标记主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模与预测（按疾病适应症）
    • 欧洲市场规模与预测（经验证）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区基因组生物标记主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按类型）
    • 亚太地区市场规模与预测（依疾病适应症）
    • 亚太地区市场规模与预测（经验证）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲基因组生物标记主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按类型）
    • 拉丁美洲市场规模与预测（按疾病适应症）
    • 拉丁美洲市场规模与预测（经验证）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲基因组生物标记主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按类型）
    • 中东和非洲市场规模及预测（依疾病指示）
    • 中东和非洲市场规模和预测（经验证）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - 基因组生物标记产业

  • 竞争仪表板
  • 公司简介
    • Thermo Fisher Scientific (US)
    • F. Hoffmann-La Roche Ltd (Switzerland)
    • Eurofins Scientific (Luxembourg)
    • FOUNDATION MEDICINE, INC. (US)
    • QIAGEN (Germany)
    • Myriad Genetics, Inc (US)
    • Bio-Rad Laboratories, Inc. (US)
    • MedGenome (India)
    • Sema4 (US)
    • GENOME LIFE SCIENCES (India)
    • Almac Group (UK)
    • Creative Diagnostics (US)
    • Quanterix (US)
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV3172

REPORT HIGHLIGHT

Genomic Biomarker Market size was valued at USD 7,684.2 Million in 2023, expanding at a CAGR of 18.20% from 2024 to 2032.

Genomic biomarkers are characteristics of DNA and RNA that are used to characterize diseases, choose treatments, and provide diagnostic information. Genomic biomarkers reflect pathological and physiological processes, as well as the reaction of the organism to treatment. One gene, a collection of genes, or the entire genome can have molecular alterations discovered by genomic biomarker testing. There may or may not be substantial supporting evidence for a connection between a genetic biomarker and the risk of contracting a disease. The clinical validity and usefulness of genomic biomarkers are influenced by two factors: genetic epidemiology data and functional laboratory assessments.

Genomic Biomarker Market- Market Dynamics

Growing Cancer Prevalence to Propel Market Growth

The market demand for genomics biomarkers is expected to increase due to the rising prevalence of various cancers, including lung, prostate, ovarian, and breast cancer. Targeting organ systems and diseases is the goal of biomarkers in human health. In particular, biomarkers are becoming more and more common in medical procedures that lead to therapy, critical care, and disease-based diagnosis. There is a growing need for genetic biomarkers worldwide in order to improve the detection and management of chronic illnesses, including cancer and cardiovascular disease. This leads to an increase in the market's demand for genomics biomarkers during the projected term.

Genomic Biomarker Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 18.20% over the forecast period (2024-2032)

Based on type segmentation, the predictive biomarkers category was predicted to show maximum market share in the year 2023

Based on disease indication segmentation, the oncology category was the leading type in 2023

Based on end user segmentation, the diagnostic category was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Genomic Biomarker Market- Segmentation Analysis:

The Global Genomic Biomarker Market is segmented on the basis of Type, Disease Indication, Validation, End User, and Region.

The market is divided into two categories based on type: Predictive Biomarkers and Prognostic Biomarkers. The predictive biomarkers category dominates the market. The reason the segment benefits is that predictive biomarkers are pretreatment or baseline data that indicate a patient's likelihood of benefiting or not from a particular treatment. When creating a particular therapeutic drug, a predictive biomarker is often selected as a companion biomarker. A common example in oncology is a biomarker that might be used to forecast when to administer trastuzumab (Herceptin) if it can identify the overexpression of the growth factor protein Her-2, which gives rise to cell proliferation in breast cancer cells. For patients with breast cancer, this medication blocks the actions of Her-2. Thus, the need for predictive biomarkers has grown as a result. Given the aforementioned claims, it can be inferred that over the forecast period, the market segment will have the greatest market share.

The market is divided into the following categories based on disease indication: Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, and Others. The oncology category dominates the market and is likely to maintain its dominance during the forecast period. The expanding number of cancer patients worldwide and the increasing technological breakthroughs in biomarker approaches are responsible for the significant stake. Recent years have seen a number of possible uses for genomic biomarkers in oncology, including risk assessment, predictive determination, screening for differential diagnoses, tracking the course of cancer, and therapy response prediction. As per the World Health Organization (WHO), cancer ranks as the second most common cause of death worldwide, taking into consideration 70% of fatalities in low- and middle-income nations. Additionally, according to WHO estimates, there were 9.6 million cancer deaths and 18.1 million new cases of cancer reported worldwide in 2018.

Genomic Biomarker Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Over the course of the forecast period, North America is anticipated to hold the greatest share of the global market for genomic biomarker. The increasing incidence of chronic illnesses brought on by the region's shifting dietary and lifestyle patterns will ensure its domination. The market for genomics biomarkers grew as a result of the pharmaceutical industry's increased use of technology. The genomic biomarker market is expected to rise as a result of increased research and development initiatives being implemented in nations like the United States, Canada, etc.

In addition, the genomic biomarker market is anticipated to expand at the fastest rate in the world during the projected period in Asia Pacific. The countries that are anticipated to have contributed the most to the market's expansion in the area are China, Japan, South Korea, and India. The significant sums of money that both public and private organizations have invested in the advancement of the pharmaceutical sector support the expansion of the Asia Pacific market. The market's expansion in Asia Pacific is anticipated to be fueled by the growing emphasis on various genetic testing initiatives and research related to the advancement of the healthcare sector.

Genomic Biomarker Market- Competitive Landscape:

Key players in the Genomic Biomarkers market include, Thermo Fisher Scientific (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Myriad Genetics, Inc (U.S.), Eurofins Scientific (Luxembourg), and QIAGEN (Germany), among others. One or more of the growth tactics highlighted is mergers and acquisitions; other strategies include trends and analysis regarding strategic collaboration among partners, mutual agreements, and partnerships. To increase their geographic presence, the major firms are implementing cutting-edge strategies for new product releases.

Recent Developments:

May 2023: The UK MHRA and Genomics England jointly stated that they have formed a joint venture to develop cutting-edge resources to comprehend how a person's genetic composition affects the safety of medications.

May 2023: The announcement was made by Kyoto University, Fujistsu, and Chordia Therapeutics regarding their strategic partnership to begin an AI trial aimed at identifying biomarkers for novel cancer treatments. These findings have led to the collaboration's goal of developing novel cancer therapies that are tailored to each patient.

October 2022: Launching its first commercial product, Biofidelity of North Carolina said that it is funding $23 million to maintain its ASPYRE-Lung diagnostic assay for lung cancer.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENOMIC BIOMARKER MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Thermo Fisher Scientific (U.S.)

F. Hoffmann-La Roche Ltd (Switzerland)

Eurofins Scientific (Luxembourg)

FOUNDATION MEDICINE, INC. (U.S.)

QIAGEN (Germany)

Myriad Genetics, Inc (U.S.)

Bio-Rad Laboratories, Inc. (U.S.)

MedGenome (India)

Sema4 (U.S.)

GENOME LIFE SCIENCES (India)

Almac Group (U.K.)

Creative Diagnostics (U.S.)

Quanterix (U.S.)

Others

GLOBAL GENOMIC BIOMARKER MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Predictive Biomarkers
  • Prognostic Biomarkers

GLOBAL GENOMIC BIOMARKER MARKET, BY DISEASE INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Cardiovascular Diseases
  • Neurological Diseases
  • Renal Disorders
  • Others

GLOBAL GENOMIC BIOMARKER MARKET, BY VALIDATION- MARKET ANALYSIS, 2019 - 2032

  • Analytical Validation
  • Clinical Validation
  • Clinical Utility

GLOBAL GENOMIC BIOMARKER MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Diagnostic
  • Research Laboratories
  • Hospitals
  • Others

GLOBAL GENOMIC BIOMARKER MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Genomic Biomarker Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Genomic Biomarker Market Snippet by Type
    • 2.1.2. Genomic Biomarker Market Snippet by Disease Indication
    • 2.1.3. Genomic Biomarker Market Snippet by Validation
    • 2.1.4. Genomic Biomarker Market Snippet by End User
    • 2.1.5. Genomic Biomarker Market Snippet by Country
    • 2.1.6. Genomic Biomarker Market Snippet by Region
  • 2.2. Competitive Insights

3. Genomic Biomarker Key Market Trends

  • 3.1. Genomic Biomarker Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Genomic Biomarker Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Genomic Biomarker Market Opportunities
  • 3.4. Genomic Biomarker Market Future Trends

4. Genomic Biomarker Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Genomic Biomarker Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Genomic Biomarker Market Landscape

  • 6.1. Genomic Biomarker Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Genomic Biomarker Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Predictive Biomarkers
    • 7.1.3. Prognostic Biomarkers

8. Genomic Biomarker Market - By Disease Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease Indication, 2023 & 2032 (%)
    • 8.1.2. Oncology
    • 8.1.3. Cardiovascular Diseases
    • 8.1.4. Neurological Diseases
    • 8.1.5. Renal Disorders
    • 8.1.6. Others

9. Genomic Biomarker Market - By Validation

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Validation, 2023 & 2032 (%)
    • 9.1.2. Analytical Validation
    • 9.1.3. Clinical Validation
    • 9.1.4. Clinical Utility

10. Genomic Biomarker Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 10.1.2. Diagnostic
    • 10.1.3. Research Laboratories
    • 10.1.4. Hospitals
    • 10.1.5. Others

11. Genomic Biomarker Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Genomic Biomarker Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Genomic Biomarker Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Genomic Biomarker Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Genomic Biomarker Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Genomic Biomarker Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Genomic Biomarker Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Thermo Fisher Scientific (U.S.)
    • 12.2.2. F. Hoffmann-La Roche Ltd (Switzerland)
    • 12.2.3. Eurofins Scientific (Luxembourg)
    • 12.2.4. FOUNDATION MEDICINE, INC. (U.S.)
    • 12.2.5. QIAGEN (Germany)
    • 12.2.6. Myriad Genetics, Inc (U.S.)
    • 12.2.7. Bio-Rad Laboratories, Inc. (U.S.)
    • 12.2.8. MedGenome (India)
    • 12.2.9. Sema4 (U.S.)
    • 12.2.10. GENOME LIFE SCIENCES (India)
    • 12.2.11. Almac Group (U.K.)
    • 12.2.12. Creative Diagnostics (U.S.)
    • 12.2.13. Quanterix (U.S.)
    • 12.2.14. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Genomic Biomarker Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Genomic Biomarker Market, by Type 2019-2032 (USD Million)
  • TABLE Genomic Biomarker Market: Disease Indication Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Disease Indication
  • TABLE Global Genomic Biomarker Market, by Disease Indication 2019-2032 (USD Million)
  • TABLE Genomic Biomarker Market: Validation Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Validation
  • TABLE Global Genomic Biomarker Market, by Validation 2019-2032 (USD Million)
  • TABLE Genomic Biomarker Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Genomic Biomarker Market, by End User 2019-2032 (USD Million)
  • TABLE Genomic Biomarker Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Genomic Biomarker Market, by Region 2019-2032 (USD Million)
  • TABLE North America Genomic Biomarker Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Genomic Biomarker Market, by Type, 2019-2032 (USD Million)
  • TABLE North America Genomic Biomarker Market, by Disease Indication, 2019-2032 (USD Million)
  • TABLE North America Genomic Biomarker Market, by Validation, 2019-2032 (USD Million)
  • TABLE North America Genomic Biomarker Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Genomic Biomarker Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Genomic Biomarker Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe Genomic Biomarker Market, by Disease Indication, 2019-2032 (USD Million)
  • TABLE Europe Genomic Biomarker Market, by Validation, 2019-2032 (USD Million)
  • TABLE Europe Genomic Biomarker Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Genomic Biomarker Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Genomic Biomarker Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Genomic Biomarker Market, by Disease Indication, 2019-2032 (USD Million)
  • TABLE Asia Pacific Genomic Biomarker Market, by Validation, 2019-2032 (USD Million)
  • TABLE Asia Pacific Genomic Biomarker Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Genomic Biomarker Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Genomic Biomarker Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America Genomic Biomarker Market, by Disease Indication, 2019-2032 (USD Million)
  • TABLE Latin America Genomic Biomarker Market, by Validation, 2019-2032 (USD Million)
  • TABLE Latin America Genomic Biomarker Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Genomic Biomarker Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Genomic Biomarker Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Genomic Biomarker Market, by Disease Indication, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Genomic Biomarker Market, by Validation, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Genomic Biomarker Market, by End User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Genomic Biomarker Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Type segment market share analysis, 2023 & 2032
  • FIGURE Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Disease Indication segment market share analysis, 2023 & 2032
  • FIGURE Disease Indication segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Validation segment market share analysis, 2023 & 2032
  • FIGURE Validation segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End User segment market share analysis, 2023 & 2032
  • FIGURE End User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Genomic Biomarker Market share and leading players, 2023
  • FIGURE Europe Genomic Biomarker Market share and leading players, 2023
  • FIGURE Asia Pacific Genomic Biomarker Market share and leading players, 2023
  • FIGURE Latin America Genomic Biomarker Market share and leading players, 2023
  • FIGURE Middle East and Africa Genomic Biomarker Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Genomic Biomarker Market share analysis by country, 2023
  • FIGURE Germany Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Genomic Biomarker Market share analysis by country, 2023
  • FIGURE India Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Genomic Biomarker Market share analysis by country, 2023
  • FIGURE Brazil Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Genomic Biomarker Market share analysis by country, 2023
  • FIGURE Saudi Arabia Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)